TELLA INC has a total of 14 patent applications. Its first patent ever was published in 2009. It filed its patents most often in Japan, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets biotechnology and pharmaceuticals are CODIAK BIOSCIENCES INC, UCHREZHDENIE ROSSIJSKOJ AKADEMII NAUK INST BIOORG KHIM IM AKADEMIKOV M M SHEMJAKINA I JU A OVCHINNIK and GLUCKSMANN MARIA ALEXANDRA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 6 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Republic of Korea | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Nishimura Takashi | 8 |
#2 | Heike Yuji | 4 |
#3 | Togashi Yuji | 4 |
#4 | Harada Yui | 3 |
#5 | Okamoto Masato | 3 |
#6 | Yoshida Hisami | 3 |
#7 | Yusa Seiichi | 3 |
#8 | Yonemitsu Yoshikazu | 3 |
#9 | Yazaki Yuichiro | 3 |
#10 | Saito Satoshi | 3 |
Publication | Filing date | Title |
---|---|---|
JP2018042481A | Compositions of antigen-specific t cells and production methods thereof | |
JP2016094458A | Methods for culturing dendritic cells | |
EP3112378A1 | Wt1 antigenic polypeptide, and anti-tumor agent containing said polypeptide | |
JP2014111631A | Culture method of dendritic cell | |
JP2013006793A | Composition and method for amplifying nk cell | |
JP2011239701A | Method for culturing dendritic cell | |
AU2009232774A1 | Partial peptide of Survivin presented on MHC class II molecule and use thereof |